Understanding Health-Related Quality of Life in Clinical Trials
Author Information
Author(s): Holger J Schünemann, Elie A Akl, Gordon H Guyatt
Primary Institution: McMaster University
Hypothesis
Can dichotomization and item response theory improve the interpretation of health-related quality of life outcomes in clinical trials?
Conclusion
Dichotomization and understanding the minimal important difference can help clinicians better interpret health-related quality of life data from clinical trials.
Supporting Evidence
- Dichotomization can help clinicians understand HRQL scores better.
- The minimal important difference is crucial for interpreting changes in HRQL.
- Clinicians often struggle to interpret complex HRQL data from clinical trials.
Takeaway
This study shows that breaking down health-related quality of life scores into simple categories can help doctors understand how patients are feeling after treatment.
Methodology
The article discusses the use of dichotomization and item response theory to interpret health-related quality of life scores.
Potential Biases
The trial was sponsored by the developer of alefacept, which may introduce bias in the interpretation of results.
Limitations
The article does not provide specific statistical methods or detailed examples of all HRQL instruments.
Participant Demographics
Patients with psoriasis were included in the study.
Statistical Information
P-Value
p<0.0001
Confidence Interval
0.18 to 1.03
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website